Aldeyra Therapeutics
ALDX
ALDX
119 hedge funds and large institutions have $328M invested in Aldeyra Therapeutics in 2023 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less capital invested
Capital invested by funds: $353M → $328M (-$25.8M)
38% less call options, than puts
Call options by funds: $5.55M | Put options by funds: $8.91M
Holders
119
Holding in Top 10
2
Calls
$5.55M
Puts
$8.91M
Top Buyers
| 1 | +$24.1M | |
| 2 | +$18.8M | |
| 3 | +$7.96M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.71M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$3.9M |
Top Sellers
| 1 | -$7.21M | |
| 2 | -$7.19M | |
| 3 | -$6.7M | |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$6.59M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$6.41M |